MARKET

PBM

PBM

Psyence Biomedical Ltd.
NASDAQ
3.280
-0.050
-1.50%
Pre Market: 3.330 +0.05 +1.52% 04:45 06/11 EDT
OPEN
3.310
PREV CLOSE
3.330
HIGH
3.400
LOW
3.235
VOLUME
402
TURNOVER
35.22K
52 WEEK HIGH
74.94
52 WEEK LOW
1.920
MARKET CAP
12.51M
P/E (TTM)
-0.1652
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PBM last week (0601-0605)?
Weekly Report · 2d ago
Psyence Biomedical Corrects Technical Error in 2023 Equity Incentive Plan
TipRanks · 5d ago
Launch One Acquisition names Daniel Clifford Rogers audit committee chair after Stack resignation
PUBT · 06/02 21:16
Weekly Report: what happened at PBM last week (0525-0529)?
Weekly Report · 06/01 10:31
Weekly Report: what happened at PBM last week (0518-0522)?
Weekly Report · 05/25 10:34
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 05/19 17:06
Weekly Report: what happened at PBM last week (0511-0515)?
Weekly Report · 05/18 10:34
Psyence BioMed targets U.S. push for GMP ibogaine research, manufacturing
PUBT · 05/16 05:17
More
About PBM
Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

Webull offers Psyence Biomedical Ltd stock information, including NASDAQ: PBM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PBM stock methods without spending real money on the virtual paper trading platform.